ProfileGDS2971 / 8.4.8.2
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 43% 9% 41% 86% 13% 76% 25% 79% 64% 45% 36% 33% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)-0.058294543
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.9475999
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-0.10487541
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)1.063486
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)-0.76968413
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.37651676
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)-0.36371425
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)0.60519979
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.25236764
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)-0.028385245
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)-0.18646336
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-0.21434933